Sekisui Diagnostics LLC of Burlington, MA at MEDICA 2021 in Düsseldorf -- COMPAMED Trade Fair
Manage stand orders
Select Option

Sekisui Diagnostics LLC

One Wall Street, 01803 Burlington, MA
USA

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Hall map

MEDICA 2021 hall map (Hall 1): stand D40

Fairground map

MEDICA 2021 fairground map: Hall 1

Our range of products

Our products

Product category: Diagnostic rapid tests

OSOM® Strep A Test

A color immunochromatographic assay intended for the qualitative detection of Group A Streptococcus antigen directly from throat swab specimens.

  • Easy-to-read two color results
  • 96% sensitivity; 98% specificity versus culture
  • Includes 2 additional test sticks for external QC testing
  • Results in 5 minutes

More Less

Product category: Diagnostic rapid tests

OSOM® Ultra Plus Flu A&B Test | CE MARKED

The OSOM® Ultra Plus Flu A & B Test is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly from nasal swab and nasopharyngeal swab specimens obtained from patients with signs and symptoms of respiratory infection.

  • Simple CLIA-waived procedure with pre-measured extraction buffer for swab samples
  • Accurate, differentiated interpretation of results in 10 minutes to test and treat patients in one office visit
  • Sample Type: Nasal swab and nasopharyngeal swab
  • Product Availability: Market authorization obtained for EU only

More Less

Product category: Diagnostic rapid tests

OSOM® RSV/Adeno Test

The OSOM® RSV/Adeno test is a rapid chromatographic immunoassay for the qualitative detection of Respiratory Syncytial Virus (RSV) and/or Adenovirus antigens directly from nasal swabs or nasal suction fluid in patients suspected of having a viral respiratory infection. Throat swabs are also an acceptable sample type for the detection of Adenovirus antigens.

  • Sensitivity versus PCR > 90% (RSV); 85% (Adenovirus)
  • Differentiates between RSV and Adenovirus
  • Easy-to-read 3 distinct lines
  • Less than 1 minute hands-on time; results in 10 minutes or less.

More Less

Product category: Diagnostic rapid tests

OSOM® Trichomonas Test

  • The only CLIA-waived rapid test for the detection of Trichomoniasis
  • 95% agreement with culture and wet mount combined
  • Detects the antigen; does not require live organism
  • Results in 10 minutes or less
  • Objective easy-to-read two-color results

More Less

Product category: Diagnostic rapid tests

OSOM® BVBLUE® Test

Detects elevated vaginal fluid sialidase activity, an enzyme produced by bacterial pathogens associated with bacterial vaginosis including Gardnerella, Bacteroides, Prevotella and Mobiluncus.

  • 92.8% sensitive, 98% specific versus Gram Stain
  • 1 minute hands-on-time; 10 minute read time
  • Instant color change provides clear easy-to-read results.

More Less

Product category: Diagnostic rapid tests

OSOM® Mono Test

For the qualitative detection of infectious mononucleosis heterophilic antibodies in serum, plasma or whole blood.

  • Results in 5 minutes
  • > 99% sensitivity ; 96% specificity
  • No age limitation
  • 2 Additional test sticks for external QC
  • Easy-to-read two color results

More Less

Product category: Diagnostic rapid tests

SEKISUI Veredus: VereRT™ ZeroPrep™ COVID-19 PCR Kit

Reverse Transcription Polymerase Chain Reaction (RT-PCR)-based In Vitro Diagnostic (IVD) test intended for the qualitative detection of nucleic acid belonging to SARS-CoV-2. This test is suitable for use directly from either (1) Viral Transport Media (VTM) / Universal Transport Media (UTM) containing nasopharyngeal swab specimen; OR (2) Human saliva specimen.

Both specimen types do not require viral RNA extraction prior to testing.

Compatibility
• VTM* / UTM* containing nasopharyngeal swab specimen
• Human saliva specimen collected using ZeroPrep™ Saliva Collection Kit
(* validated with 5 different brands of VTM / UTM)

Gene Targets
• Dual N1 and N2 gene targets (FAM)
• Human RPP30 as Internal Control (HEX)

Time-to-Result
• Approximately 90 mins

Sensitivity
• 10 viral RNA copies per test (4 viral RNA copies per uL Saliva)

Specificity
• No cross-reactivity with human genome / other coronaviruses / respiratory viruses

Territories
Europe, Middle East and Africa

 

More Less

About us

Company portrait

Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan.

Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents.

We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners.  Our product lines include:
  • Clinical chemistry reagents
  • Coagulation reagents
  • Point-of-care rapid tests and immunoassay system
  • Enzymes and specialty biochemicals